Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Glecaprevir/pibrentasvir investigational HCV regimen receives FDA breakthrough therapy designation

Oct. 3, 2016

Bill & Melinda Gates Foundation gives grant to Sirenas

Oct. 3, 2016

Hetero Research Foundation develops antiviral agents

Oct. 3, 2016

Phase IIb trial of Genocea's GEN-003 achieves primary endpoint

Sep. 30, 2016

Arbutus Biopharma reports interim results from phase II trial of ARB-1467 in chronic HBV

Sep. 30, 2016

Redx compounds effective against drug-resistant strains of Gram-negative bacteria

Sep. 28, 2016

Emory University discloses RNA-directed RNA polymerase inhibitors

Sep. 27, 2016

Vical starts phase II trial of VCL-HB01 in HSV-2 infection

Sep. 27, 2016

FDA grants fast track designation to PfSPZ vaccine

Sep. 23, 2016

Phase IIb results for the GMZ-2 malaria vaccine in African children

Sep. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026